LILETTA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Liletta, and when can generic versions of Liletta launch?
Liletta is a drug marketed by Medicines360 and is included in one NDA. There are four patents protecting this drug.
This drug has thirty-three patent family members in nineteen countries.
The generic ingredient in LILETTA is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Liletta
A generic version of LILETTA was approved as levonorgestrel by NOVEL LABS INC on February 22nd, 2013.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LILETTA?
- What are the global sales for LILETTA?
- What is Average Wholesale Price for LILETTA?
Summary for LILETTA
International Patents: | 33 |
US Patents: | 4 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Clinical Trials: | 2 |
Patent Applications: | 3,720 |
Drug Prices: | Drug price information for LILETTA |
What excipients (inactive ingredients) are in LILETTA? | LILETTA excipients list |
DailyMed Link: | LILETTA at DailyMed |
Recent Clinical Trials for LILETTA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Kenya Medical Research Institute | Phase 4 |
Eastern Virginia Medical School | Phase 4 |
CONRAD | Phase 4 |
Pharmacology for LILETTA
Drug Class | Progestin Progestin-containing Intrauterine System |
Physiological Effect | Inhibit Ovum Fertilization |
US Patents and Regulatory Information for LILETTA
LILETTA is protected by four US patents and one FDA Regulatory Exclusivity.
Patents protecting LILETTA
Intrauterine systems, IUD insertion devices, and related methods and kits therefor
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD FOR PREVENTION OF PREGNANCY
Methods for using intrauterine systems and IUD insertion devices
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD FOR PREVENTION OF PREGNANCY
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
FDA Regulatory Exclusivity protecting LILETTA
TREATMENT OF HEAVY MENSTRUAL BLEEDING FOR UP TO 5 YEARS IN PATIENTS WHO CHOOSE INTRAUTERINE CONTRACEPTION AS THEIR METHOD OF CONTRACEPTION
Exclusivity Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medicines360 | LILETTA | levonorgestrel | SYSTEM;INTRAUTERINE | 206229-001 | Feb 26, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Medicines360 | LILETTA | levonorgestrel | SYSTEM;INTRAUTERINE | 206229-001 | Feb 26, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Medicines360 | LILETTA | levonorgestrel | SYSTEM;INTRAUTERINE | 206229-001 | Feb 26, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Medicines360 | LILETTA | levonorgestrel | SYSTEM;INTRAUTERINE | 206229-001 | Feb 26, 2015 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for LILETTA
See the table below for patents covering LILETTA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Brazil | 112020019403 | dispositivos de introdução de diu, e métodos relacionados e kits para os mesmos | ⤷ Sign Up |
Canada | 2841855 | SYSTEMES INTRA-UTERINS, DISPOSITIFS D'INTRODUCTION DE DISPOSITIF INTRA-UTERIN (IUD), ET PROCEDES ASSOCIES ET TROUSSES POUR CEUX-CI (INTRAURINARY SYSTEMS, IUD INSERTION DEVICES, AND RELATED METHODS AND KITS THEREFOR) | ⤷ Sign Up |
China | 111902107 | IUD插入装置和相关方法以及用于其的套件 (IUD insertion devices, and related methods and kits therefor) | ⤷ Sign Up |
Spain | 2694173 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for LILETTA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1453521 | C 2015 029 | Romania | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL SI ETINILESTRADIOL; NATIONAL AUTHORISATION NUMBER: RO 7793/2015/001; DATE OF NATIONAL AUTHORISATION: 20150612; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): SK. 17/0017/15-S; DATE OF FIRST AUTHORISATION IN EEA: 20150129 |
1453521 | 15C0050 | France | ⤷ Sign Up | PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129 |
1453521 | 132016000025143 | Italy | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL ED ETINILESTRADIOLO(SEASONIQUE); AUTHORISATION NUMBER(S) AND DATE(S): 17/0017/15-S, 20150211;042139016, 20150414 |
1453521 | CA 2016 00016 | Denmark | ⤷ Sign Up | PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |